Tregs in TME can reduce the content of IL-2 in TME and promote the expression of CTLA4 by producing immunosuppressive components such as TGF-β, IL-10 and extracellular adenosine, thus inhibiting the physiological function of CD8+ T cells and favouring immune evasion of melanoma cells [86]. The gene discussed is CTLA4; the disease is melanoma.